Udvalget for Humanmedicinske Lægemidler (CHMP) konkluderede, at fordelene ved Liprolog er større end risiciene ved behandling af diabetes mellitus.
The Committee for Medicinal Products for Human Use (CHMP) decided that Liprolog’ s benefits are greater than its risks for the treatment of diabetes mellitus.